Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Clin Immunol. 2012 Feb 7;143(2):152–161. doi: 10.1016/j.clim.2012.01.014

Figure 2.

Figure 2

Clinical treatment design. The patient was treated weekly infusions of CD870,893 as follows: 0.5 mg/kg for 2 weeks, 0.10 mg/kg for 6 weeks, 0.2 mg/kg for 2 weeks, and 0.3 mg/kg for 14 weeks. Following this 24-week period, the patient was infused with CD870, 893 at 0.2 mg/kg two times per week for 10 weeks, after which the frequency at 0.2 mg/kg dose was increased to three times per week for an additional 10 weeks for a total of 44 weeks of treatment. Serial stool examination showed fewer Cryptosporidium cysts when CP970,893 was administered at higher or more frequent doses.